THE SHORT VERSION
- Wegovy 7.2mg MHRA news, GLP-1 safety guidance, GPhC safeguards and advertising rules for UK weight-loss medicines.
Wegovy 7.2mg MHRA approval
MHRA approval of Wegovy up to 7.2mg — adult patients with obesity, prescriber-led.
Sources you can check
Editorial presentation updated 24 October 2026. This is general information, not individual medical advice or a claim of independent clinical review. Read the linked source and the leaflet supplied with your medicine for the full context. Suggest a correction.